Market Research Report
Global Markets for Implantable Biomaterials
|Published by||BCC Research||Product code||321809|
|Published||Content info||229 Pages
Delivery time: 1-2 business days
|Global Markets for Implantable Biomaterials|
|Published: January 1, 2015||Content info: 229 Pages||
The global market for implantable biomaterials in 2013 was worth nearly $75.1 billion. This market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2014 and 2019. This will result in $79.1 billion in 2014 and $109.5 billion global market in 2019.
This report provides: An overview of the global market for biomaterials used in medical applications. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019. Segmentation of the biomaterials based on the materials from which they are made including metallic, ceramic, polymeric, natural and composite materials. Segmentation based on therapeutic or application area including orthopaedic, cardiovascular, dental, immunology and infection, pulmonary/respiratory disease, plastic surgery, ophthalmology, oncology, neurology, and more. Comprehensive profiles of leading companies in the industry.
This market research report focuses on the global market for medical biomaterials by geographic region and by market segment, and also provides an in-depth discussion and analysis of the application of biomaterials and a review of new and developing technology platforms. This report also examines companies that are actively developing and marketing medical biomaterials around the world. Detailed tables and charts with sales forecasts and market share data are also included.
Products that are used as biomaterials can be segmented by the materials from which they are made; for example:
In addition to the segmentation by material type, medical biomaterials can also be examined by application/therapeutic area as follows:
The global market for medical biomaterials has been estimated at $48 billion in 2013, and is expected to more than double by 2019, reaching $102.5 billion. The growth represents a compound annual growth rate (CAGR) of by the end of the forecast period.
In 2013, the cardiovascular biomaterial segment represented the largest single market segment, accounting for 34.5% of the global biomaterial market, followed by the orthopedic segment. Plastic surgery and wound healing applications are expected to experience the highest growth in the coming years. North America is the largest market for biomaterials and is expected to grow at CAGR of 5.2% from 2014 to 2019 due to an increase in the aging population.
Due to rising awareness of biomaterial products in Asia, and increased partnerships and collaborations, the Asian market is expected to grow at a CAGR of 21.5% from 2014 to 2019.
The author is an independent market analyst for the medical industry with a BSc and PhD in Biochemistry from the University of Liverpool and an MBA from Oxford Brookes University. The author worked in the medical industry as a senior marketing executive for 20 years, creating and implementing strategic business and marketing plans for major multinational medical device companies before establishing himself as an independent research analyst.
For the last 15 years, the author has worked extensively in managing and conducting market research projects in key healthcare markets to determine market conditions, product attributes, issues and opinions. This data and information has been used to analyze specific product global market segments, and to create and implement strategic business and marketing plans for major multinational companies to launch new products and product line extensions, as well as to re-market existing product lines.
The author has also acquired knowledge and experience with a wide range of software applications including predictive analytical software such as SPSS, Stata and SAS as a means of obtaining logistic regression, statistical variance analysis and mixed model analysis of market research data. This form of analysis has been used recently to prepare a variety of customized strategic marketing plans for individual clients in the biopharmaceutical and biotechnology industries.